Ticker Details
Tango Therapeutics, Inc.
IPO Date:	September 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.95B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 3.80%
Avg Daily Range (30 D):	$0.69 | 4.38%
Avg Daily Range (90 D):	$0.44 | 3.43%

Institutional Daily Volume
Avg Daily Volume:	.95M
Avg Daily Volume (30 D):	3.2M
Avg Daily Volume (90 D):	2.64M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	98
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	1,217
Avg Institutional Trade:	$1.86M
Avg Institutional Trade (30 D):	$2.38M
Avg Institutional Trade (90 D):	$2.28M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.18M
Avg Closing Trade (30 D):	$6.97M
Avg Closing Trade (90 D):	$4.45M
Avg Closing Volume:	238.36K

News

Mar 19, 2026 @ 3:00 PM The Patent Cliff is Coming, Driving Smart Money To... Source: Equity-Insider.Com

Mar 6, 2026 @ 10:33 PM Tango Therapeutics Announces Inducement Grants Und... Source: Na

Mar 4, 2026 @ 11:15 PM Investment Firm Bets Big on TNGX Stock With $9.5 M... Source: Jake Lerch

Jan 5, 2026 @ 12:00 PM Tango Therapeutics Appoints Sung Lee to Board of D... Source: Na

Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.87	$-.3	$-.87
Diluted EPS	$-.87	$-.3	$-.87
Revenue	$62.38M	$M	$62.38M
Gross Profit
Net Income / Loss	$-101.59M	$-38.75M	$-101.59M
Operating Income / Loss	$-111.29M	$-41.86M	$-111.29M
Cost of Revenue
Net Cash Flow	$42.75M	$53.94M	$42.75M
PE Ratio